Azithromycin in patients with COVID-19: a systematic review and meta-analysis
Volume: 77, Issue: 2, Pages: 303 - 309
Published: Nov 17, 2021
Abstract
Azithromycin has been widely used in the management of COVID-19. However, the evidence on its actual effects remains disperse and difficult to apply in clinical settings. This systematic review and meta-analysis summarizes the available evidence to date on the beneficial and adverse effects of azithromycin in patients with COVID-19.The PRISMA 2020 statement criteria were followed. Randomized controlled trials (RCTs) and observational studies...
Paper Details
Title
Azithromycin in patients with COVID-19: a systematic review and meta-analysis
Published Date
Nov 17, 2021
Volume
77
Issue
2
Pages
303 - 309
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History